NETWORK META-ANALYSIS: COMPARATIVE EFFICACY OF BIOLOGICS IN THE TREATMENT OF BIOLOGIC-NAiVE JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引：0
|
作者：
Hibi, Toshihumi
Kamae, Isao
Pinton, Philippe
Ursos, Lyann
Iwakiri, Ryuichi
Hather, Greg
Patel, Haridarshan
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2019年 / 25卷
关键词：
D O I：
10.1093/ibd/izy393.043
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P038
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
    Jairath, Vipul
    Raine, Tim
    Leahy, Thomas P.
    Potluri, Ravi
    Wosik, Karolina
    Gruben, David
    Cappelleri, Joseph C.
    Hur, Peter
    Bartolome, Lauren
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2025,
  • [42] Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naive Patients with Moderate-to-Severe Ulcerative Colitis in Japan
    Kobayashi, Taku
    Hoshi, Masato
    Yuasa, Akira
    Arai, Shoko
    Ikeda, Mitsunobu
    Matsuda, Hiroyuki
    Kim, Seok-Won
    Hibi, Toshifumi
    PHARMACOECONOMICS, 2023, 41 (05) : 589 - 604
  • [43] Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)
    Welty, M.
    Mesana, L.
    Padhiar, A.
    Naessens, D.
    Diels, J.
    van Sanden, S.
    Pacou, M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (09) : 1569 - 1569
  • [44] Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
    Zhang, Zong Mei
    Li, Wei
    Jiang, Xue Liang
    GUT AND LIVER, 2016, 10 (02) : 262 - 274
  • [45] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Doug
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S20 - S21
  • [46] Long-Term Efficacy of Adalimumab for Treatment of Moderately to Severely Active Ulcerative Colitis
    Colombel, Jean-Frederic
    Sandborn, William
    Wolf, Douglas
    Panaccione, Remo
    Lazar, Andreas
    Kron, Martina
    Robinson, Anne
    Thakkar, Roopal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S652 - S652
  • [47] Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Yasuo Suzuki
    Satoshi Motoya
    Hiroyuki Hanai
    Toshifumi Hibi
    Shiro Nakamura
    Andreas Lazar
    Anne Martin Robinson
    Martha Skup
    Nael Mohamed Mostafa
    Bidan Huang
    Roopal Thakkar
    Mamoru Watanabe
    Journal of Gastroenterology, 2017, 52 : 1079 - 1079
  • [48] Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis (2017)
    Suzuki, Yasuo
    Motoya, Satoshi
    Hanai, Hiroyuki
    Hibi, Toshifumi
    Nakamura, Shiro
    Lazar, Andreas
    Robinson, Anne Martin
    Skup, Martha
    Mostafa, Nael Mohamed
    Huang, Bidan
    Thakkar, Roopal
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (09) : 1079 - 1079
  • [49] ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.
    Borisova, M.
    Lukina, G.
    Yakov, S.
    Luchikhina, E.
    Karateev, D.
    Novikov, A.
    Aleksandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1300 - 1300
  • [50] The comparative efficacy and safety of biologics and small molecules for treating patients with ulcerative colitis in Portugal: a systematic literature review and network meta-analysis
    Gonzalez, Y. Sanchez
    Prata, R.
    Alves, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (14) : 6744 - 6759
12345